Ani Pharmaceuticals Inc - ANIP

Latest data: 4/29/2025 10:06:56 PM
EDGAR CIK 0001023024

Buy Breakdown

Total $0

Sell Breakdown

Total $16,311,377

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
04/14/2025
10b5-1
04/14/2025
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-400 @ $68.96
($27,584.00)
80,145 (-0.50%) Direct
03/19/2025
10b5-1
03/20/2025
SVP, CHIEF HR OFFICER
Officer
Sell
-1,866 @ $65.00
($121,290.00)
64,659 (-2.80%) Direct
03/13/2025
10b5-1
03/14/2025
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-400 @ $63.33
($25,332.00)
80,545 (-0.49%) Direct
03/07/2025
10b5-1
03/10/2025
SVP, CHIEF HR OFFICER
Officer
Sell
-1,000 @ $60.86
($60,860.00)
66,525 (-1.48%) Direct
02/21/2025
10b5-1
02/24/2025
SVP, CHIEF HR OFFICER
Officer
Sell
-1,000 @ $60.20
($60,200.00)
68,624 (-1.44%) Direct
02/13/2025
10b5-1
02/18/2025
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-400 @ $59.54
($23,816.00)
83,478 (-0.48%) Direct
01/13/2025
10b5-1
01/13/2025
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-400 @ $53.92
($21,568.00)
55,588 (-0.71%) Direct
12/17/2024
12/18/2024
SVP & CFO
CFO
Sell
-7,500 @ $55.79
($418,425.00)
154,468 (-4.63%) Direct
12/13/2024
10b5-1
12/16/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $56.24
($14,060.00)
55,988 (-0.44%) Direct
12/11/2024
10b5-1
12/12/2024
SVP, CHIEF HR OFFICER
Officer
Sell
-1,000 @ $60.00
($60,000.00)
49,059 (-2.00%) Direct
11/15/2024
11/18/2024
HEAD OF RARE DISEASE
Officer
Sell
-6,500 @ $57.70
($375,050.00)
76,777 (-7.81%) Direct
11/13/2024
10b5-1
11/14/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $61.36
($15,340.00)
56,238 (-0.44%) Direct
10/14/2024
10b5-1
10/15/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $57.19
($14,297.50)
56,488 (-0.44%) Direct
09/13/2024
10b5-1
09/16/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $56.82
($14,205.00)
56,738 (-0.44%) Direct
08/13/2024
10b5-1
08/14/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $59.62
($14,905.00)
56,988 (-0.44%) Direct
07/18/2024
10b5-1
07/19/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-2,743 @ $62.00
($170,066.00)
632,620 (-0.43%) Indirect - Held by Esjay LLC
07/17/2024
10b5-1
07/17/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-14,257 @ $63.16
($900,472.12)
635,363 (-2.19%) Indirect - Held by Esjay LLC
07/16/2024
10b5-1
07/17/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-22,000 @ $64.27
($1,413,940.00)
649,620 (-3.28%) Indirect - Held by Esjay LLC
07/15/2024
10b5-1
07/17/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-11,000 @ $63.38
($697,180.00)
671,620 (-1.61%) Indirect - Held by Esjay LLC
07/12/2024
10b5-1
07/15/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $64.91
($16,227.50)
58,981 (-0.42%) Direct
07/01/2024
10b5-1
07/02/2024
SVP - CORP. DEV. & STRATEGY
Officer
Sell
-20,000 @ $63.44
($1,268,800.00)
193,226 (-9.38%) Indirect - Held by Chali Properties LLC
06/21/2024
10b5-1
06/24/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-20,000 @ $58.90
($1,178,000.00)
682,620 (-2.85%) Indirect - Held by Esjay LLC
06/20/2024
10b5-1
06/20/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-11,447 @ $59.86
($685,217.42)
702,620 (-1.60%) Indirect - Held by Esjay LLC
06/18/2024
10b5-1
06/20/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-10,607 @ $60.76
($644,481.32)
714,067 (-1.46%) Indirect - Held by Esjay LLC
06/17/2024
10b5-1
06/20/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-7,946 @ $61.41
($487,963.86)
724,674 (-1.08%) Indirect - Held by Esjay LLC
06/13/2024
10b5-1
06/14/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $63.80
($15,950.00)
59,231 (-0.42%) Direct
06/05/2024
06/06/2024
SVP, GENERICS
Officer
Sell
-2,985 @ $67.00
($199,995.00)
77,227 (-3.72%) Direct
06/04/2024
06/06/2024
SVP & CFO
CFO
Sell
-5,000 @ $63.58
($317,900.00)
161,968 (-2.99%) Direct
06/03/2024
10b5-1
06/04/2024
SVP - CORP. DEV. & STRATEGY
Officer
Sell
-20,000 @ $64.41
($1,288,200.00)
213,226 (-8.58%) Indirect - Held by Chali Properties LLC
05/21/2024
05/22/2024
HEAD OF RARE DISEASE
Officer
Sell
-2,000 @ $61.61
($123,220.00)
83,277 (-2.35%) Direct
05/20/2024
10b5-1
05/21/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-12,855 @ $61.81
($794,567.55)
732,620 (-1.72%) Indirect - Held by Esjay LLC
05/17/2024
10b5-1
05/17/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-5,836 @ $62.09
($362,357.24)
745,475 (-0.78%) Indirect - Held by Esjay LLC
05/16/2024
10b5-1
05/17/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-16,459 @ $63.84
($1,050,742.56)
751,311 (-2.14%) Indirect - Held by Esjay LLC
05/15/2024
10b5-1
05/17/2024
HEAD OF R&D, COO-NOVITIUM OPS
Officer Director
Sell
-14,850 @ $65.86
($978,021.00)
767,770 (-1.90%) Indirect - Held by Esjay LLC
05/14/2024
05/16/2024
PRESIDENT & CEO
CEO Director
Sell
-16,669 @ $66.10
($1,101,820.90)
377,505 (-4.23%) Direct
05/13/2024
10b5-1
05/13/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $67.69
($16,922.50)
59,481 (-0.42%) Direct
05/01/2024
10b5-1
05/03/2024
SVP - CORP. DEV. & STRATEGY
Officer
Sell
-20,000 @ $66.62
($1,332,400.00)
233,226 (-7.90%) Indirect - Held by Chali Properties LLC